These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
127 related articles for article (PubMed ID: 1704938)
1. [Immunohistochemical studies on bladder tumours. Evaluation by CEA, ferritin, beta 2-MG, keratin and glycogen]. Onodera Y Nihon Hinyokika Gakkai Zasshi; 1990 Nov; 81(11):1649-53. PubMed ID: 1704938 [TBL] [Abstract][Full Text] [Related]
2. [Immunohistochemical studies on bladder tumours. Immunohistochemical evaluation on intravesical therapy for bladder tumours]. Onodera Y Nihon Hinyokika Gakkai Zasshi; 1990 Nov; 81(11):1654-8. PubMed ID: 1704939 [TBL] [Abstract][Full Text] [Related]
3. Behavior of epithelial differentiation antigens (carcinoembryonic antigen, epithelial membrane antigen, keratin and cytokeratin) in transitional cell carcinomas of the bladder. Sánchez-Fernández de Sevilla MC; Morell-Quadreny L; Gil-Salom M; Pérez-Bacete M; Fenollosa-Entrena B; Llombart-Bosch A Urol Int; 1992; 48(1):14-9. PubMed ID: 1376008 [TBL] [Abstract][Full Text] [Related]
4. Micropapillary variant of urothelial carcinoma of the urinary bladder; a clinicopathological and immunohistochemical study. Samaratunga H; Khoo K Histopathology; 2004 Jul; 45(1):55-64. PubMed ID: 15228444 [TBL] [Abstract][Full Text] [Related]
5. [Immunohistochemical determination of antigen 19-9 (CA 19-9) in transitional carcinoma of the bladder]. Casetta G; Cavallini A; Piana P; Squintone L; Vottero M; Tizzani A Minerva Urol Nefrol; 1992; 44(3):169-72. PubMed ID: 1492266 [TBL] [Abstract][Full Text] [Related]
6. [Immunohistochemical localization of epithelial membrane antigen, carcinoembryonic antigen and secretory component in urinary bladder cancer]. Takashi M; Murase T; Mitsuya H; Koshikawa T; Nagura H; Haimoto H Hinyokika Kiyo; 1986 Apr; 32(4):541-52. PubMed ID: 2426931 [TBL] [Abstract][Full Text] [Related]
7. Keratin, luminal epithelial antigen and carcinoembryonic antigen in human urinary bladder carcinomas. An immunohistochemical study. Nathrath WB; Arnholdt H; Wilson PD Pathol Res Pract; 1982; 175(2-3):299-307. PubMed ID: 6190152 [TBL] [Abstract][Full Text] [Related]
8. [Immunohistochemical demonstration of carcinoembryonic antigen (CEA) and ABO (H) blood group antigens on tissue sections of urinary bladder tumors]. Fujioka T; Tanji S; Koike H; Kubo T; Ohhori T Hinyokika Kiyo; 1985 Oct; 31(10):1709-16. PubMed ID: 3911765 [TBL] [Abstract][Full Text] [Related]
10. Immunohistochemical demonstration of carcinoembryonic antigen (CEA) and its correlation with grading and staging on tissue sections of urinary bladder carcinomas. Jautzke G; Altenaehr E Cancer; 1982 Nov; 50(10):2052-6. PubMed ID: 6751517 [TBL] [Abstract][Full Text] [Related]
11. The expression of beta human chorionic gonadotrophin (β-HCG) in human urothelial carcinoma. Venyo AK; Herring D; Greenwood H; Maloney DJ Pan Afr Med J; 2010; 7():20. PubMed ID: 21918707 [TBL] [Abstract][Full Text] [Related]
12. Transitional cell carcinomas of the ovary and bladder are immunophenotypically different. Ordóñez NG Histopathology; 2000 May; 36(5):433-8. PubMed ID: 10792484 [TBL] [Abstract][Full Text] [Related]
13. Epithelial differentiation antigens and epidermal growth factor receptors in transitional cell bladder carcinoma: correlation with prognosis. Nakopoulou L; Zervas A; Constantinides C; Deliveliotis C; Stefanaki K; Dimopoulos C Urol Int; 1995; 54(4):191-7. PubMed ID: 7541921 [TBL] [Abstract][Full Text] [Related]
14. Immunohistochemical staining for keratin and carcinoembryonic antigen in the diagnosis of malignant mesothelioma. Holden J; Churg A Am J Surg Pathol; 1984 Apr; 8(4):277-9. PubMed ID: 6201076 [TBL] [Abstract][Full Text] [Related]
15. Immunohistochemical demonstration of tumor-associated antigens with the aid of monoclonal and polyclonal antisera in carcinoma of the bladder. Steffens J; Friedmann W; Lobeck H Urol Res; 1985; 13(2):55-9. PubMed ID: 2409654 [TBL] [Abstract][Full Text] [Related]
16. [Assessment of serum ferritin, CEA, beta 2-MG and PAP determinations in patients with urinary tract malignancies]. Ohashi T; Tohjoh S; Takeda K; Kumon H; Morioka M; Matsumura Y; Ohmori H; Suyama B; Hironaka K Hinyokika Kiyo; 1983 Feb; 29(2):141-53. PubMed ID: 6375313 [TBL] [Abstract][Full Text] [Related]
17. High molecular weight cytokeratin antibody (clone 34betaE12): a sensitive marker for differentiation of high-grade invasive urothelial carcinoma from prostate cancer. Varma M; Morgan M; Amin MB; Wozniak S; Jasani B Histopathology; 2003 Feb; 42(2):167-72. PubMed ID: 12558749 [TBL] [Abstract][Full Text] [Related]
18. [Immunohistochemical demonstration of tumor-associated antigens in urinary bladder carcinomas using mono- and polyclonal antisera]. Friedmann W; Steffens J; Lobeck H Onkologie; 1985 Apr; 8(2):105-10. PubMed ID: 2582324 [TBL] [Abstract][Full Text] [Related]
19. [Isoantigens ABH in bladder tumors as an indicator of malignant potential. Criteria for the loss of BGA based on the staining pattern by the PAP method and its correlation with CEA and fibronectin]. Nasu Y Nihon Hinyokika Gakkai Zasshi; 1986 Jun; 77(6):977-87. PubMed ID: 3534405 [No Abstract] [Full Text] [Related]
20. An immunohistochemical study of keratin, carcinoembryonic antigen, human chorionic gonadotropin and alpha-fetoprotein in lung cancer. Kimura N; Ghandur-Mnaymen L Tohoku J Exp Med; 1985 Jan; 145(1):23-38. PubMed ID: 2580364 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]